Gurgaon - July 19, 2023 - ExtraCare Diagnostics, a leading pathology laboratory for comprehensive diagnostic services, is proud to announce the launch of its groundbreaking diagnostic test designed to detect cancer at its earliest stages. This revolutionary advancement in medical diagnostics aims to improve patient outcomes by enabling early detection and timely treatment interventions.
According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, with millions of lives lost each year. Early detection plays a critical role in increasing survival rates and improving the quality of life for cancer patients. Recognizing this need, ExtraCare Diagnostics has developed a state-of-the-art diagnostic test that can identify the presence of cancerous cells even before symptoms manifest.
The newly launched diagnostic test utilizes cutting-edge technology and sophisticated algorithms to analyze blood samples for the presence of specific biomarkers associated with various types of cancer. By leveraging artificial intelligence and machine learning, the test provides highly accurate results, enabling healthcare professionals to detect cancer at its earliest stages.
"Early detection is key in the fight against cancer, as it allows for timely intervention and better treatment outcomes "Our groundbreaking diagnostic test is designed to empower healthcare providers with an effective tool to detect cancer in its earliest form, when treatment options are most effective."

The ExtraCare Diagnostics test is non-invasive and offers a simple, cost-effective, and time-efficient alternative to traditional screening methods. By requiring only a blood sample, the test eliminates the need for invasive procedures, such as biopsies, reducing patient discomfort and enhancing overall patient experience.
Furthermore, the diagnostic test has demonstrated exceptional accuracy in clinical trials. By detecting cancer at its earliest stages, it provides an opportunity for healthcare providers to intervene proactively, potentially saving lives and reducing the burden of treatment for patients and healthcare systems.
ExtraCare Diagnostics is committed to advancing cancer detection technologies and revolutionizing the field of diagnostics. Through ongoing research and development, the company is constantly working to enhance the accuracy and efficiency of its diagnostic test. By staying at the forefront of scientific innovation, ExtraCare Diagnostics aims to make significant contributions to the early detection and treatment of cancer.
"We are incredibly proud of this groundbreaking achievement "Our diagnostic test represents a major step forward in the field of cancer detection, and we believe it has the potential to save countless lives and improve patient outcomes. We are excited to collaborate with healthcare providers to bring this test to patients around the world."
To learn more about ExtraCare Diagnostics and their innovative diagnostic test for early cancer detection, please visit their website at https://extracarediagnostics.com/
About ExtraCare Diagnostics:
ExtraCare Diagnostics is a leading pathology laboratory for comprehensive diagnostic services dedicated to transforming the field of diagnostics through innovation. The company focuses on the development of groundbreaking diagnostic tests that enable early disease detection, with an emphasis on cancer. By leveraging state-of-the-art technology and artificial intelligence, ExtraCare Diagnostics aims to improve patient outcomes and contribute to global efforts in fighting diseases.